Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Results for the year ended 31 December 2017

4 Jun 2018 14:08

RNS Number : 2224Q
Path Investments plc
04 June 2018
 

4 June 2018

 

Path Investments plc

("Path" or the "Company")

 

Annual Results for the year ended 31 December 2017

 

Path Investments plc (TIDM: PATH) is pleased to announce its audited results for the year ended 31 December 2017.

 

Highlights

· Admission to the Standard List segment of the London Stock Exchange Official List concluded

· Current focus on the acquisition of conventional onshore producing European Gas assets

· Conditional Farm-In Agreement signed 14 December 2017, which, subject to completion, will be the Company's first acquisition under its new stated strategy

· Subsequent to year-end, a move to the AIM market is planned with an accompanying fund raising

 

 

For further information please contact:

 

Path Investments plc

Christopher Theis

Andy Yeo

 

020 3934 6632

Shard Capital (Broker and Financial Adviser)

Simon Leathers

Damon Heath

 

020 7186 9900

IFC Advisory (Financial PR & IR)

Tim Metcalfe

Heather Armstrong

Miles Nolan

020 3934 6630

 

Chairman's Statement

The Company was successfully admitted to the Standard List segment of the Official List of the London Stock Exchange on the 30 March 2017 ("Admission").

Post Admission, the Directors immediately set about pro-actively reviewing a number of opportunities as they presented themselves. Those assets found to be of most interest at this time are within the European conventional onshore producing gas area. The Directors are aware of a number of such opportunities, at differing stages of transaction maturity, and have focused time and resources to advance one particular transaction at this time towards completion.

A Conditional Farm-In Agreement was signed with 5P Energy GmbH on 14 December 2017 for the acquisition of a 50% Participating interest in the producing Alfeld-Elze II Licence and gas field in Lower Saxony, Germany (the "Proposed Transaction"). Alfeld Elze II has been in production since 2015 from the re-entered H-WD Z2 vertical well. The re-drilling of a second well, the A-EZ Z4(2) well, was completed in February 2018 and subject to testing, final approvals and commissioning, production from A-EZ Z4(2) is anticipated to commence around mid-2018.

This acquisition fits with the Company's stated strategy: it allows rapid deployment of capital into an existing, producing asset, it is low risk with a proven measured reserve, and the field holds development potential to generate long term cash flow. To assist with this acquisition, and others that may follow, a fund raising and an accompanying move to the AIM market of the London Stock Exchange is planned. At this time, the Directors are focused on delivering an efficient financial structure for the Proposed Transaction.

In addition to seeking to deliver significant near-term increases in gas production from Alfeld-Elze II, the Directors intend to continue to build a low risk and, over time, diversified, oil and gas portfolio which has the ability to provide the Company's shareholders with a dividend stream as well as offering development potential.

Nigel Brent Fitzpatrick

Non -Executive Chairman

 

Operational Review

The Company was incorporated and registered in England and Wales on 2 June 2000 under the Companies Act 1985 as a public company limited by shares with the name Hallco 459 plc and with registered number 04006413. On 28 November 2000, the Company changed its name to The Niche Group PLC. On 20 February 2016, the Company changed its name to Path Investments Plc. It is domiciled and its principal place of business is in the United Kingdom and is subject to the City Code.

The strategy of the Company is to acquire interests in oil and gas production or near production assets with the objective of providing the Company's shareholders with access to a low risk and, over time, diversified oil and gas portfolio which can offer a dividend stream as well as offering development potential for capital growth. The Directors are looking to create a diversified portfolio of assets that is mindful of the maturity of asset developments, life of income stream and the potential for growth.

The Company was admitted to the Official List by way of a Standard Listing and to trading on the London Stock Exchange's Main Market for listed securities on 30 March 2017. At the time of listing accrued salaries, pensions and benefits in kind amounting to £940,905 were waived and the Company raised approximately £1.4 million before expenses through the subscription of new ordinary shares.

The Company has not traded over the past twelve months and no material level of interest income has been received to date. Over that period its expenses have related to pre-deal costs, professional and associated expenses related to the Standard Listing, placing, advisory and consultancy fees, along with general administration expenses.

The previous sustained period during which oil was priced at US$100 a barrel or more had seen companies in the sector raise their appetite for risk; not just in exploration activity but also by investing in high cost appraisal and development programmes. The subsequent fall in commodity prices has led to pressure on project commitments and cash flow shortages which have left many proven and producing projects starved of capital. This is particularly acute at the smaller end of the quoted sector where exploration exposure is much higher.

The Directors believe that attractive opportunities currently exist to acquire interests in energy assets, and in particular onshore European gas assets, which are profitable and have future development potential. In addition to the decreased costs at which interests in assets can be acquired in the current climate, new entrant advantages include ongoing reductions in project costs along with, in many cases, the benefits of significant historically incurred costs, existing infrastructure and technical understanding. Revenue generation from some of these assets can be either immediate or imminent.

The Company intends to focus on identifying acquisition opportunities which are, in the opinion of the Directors, underperforming, undeveloped and/or currently undervalued, and where the Directors believe that their expertise and experience, in conjunction with that of the incumbent management, can be deployed to facilitate growth and unlock inherent value.

On 15 December 2017 the Company announced that it had entered into a Conditional Farm-In Agreement with 5P Energy GmbH, under which Path will acquire a 50% Participating Interest in the Alfeld-Elze II License and field, subject to completion. Upon completion, this would be the Company's first acquisition under its new stated strategy. The Directors believe that admission to AIM, and the cancellation of its existing admission to the Standard Segment of the Main Market of the London Stock Exchange, will be appropriate at that time to assist with this acquisition and others that may follow.

 

Financial Review

Loss for the year

In the year ended 31 December 2017, the Company recorded a loss of £623,977 after deducting £400,346 in respect of share based payments. There was no income in the period.

Cash flow

In March 2017, the Company issued 140 million additional Ordinary Shares for a subscription price of £0.01, raising £1.4 million before expenses in relation to its Listing on the Standard Segment of The London Stock Exchange.

 

Strategic Report

The directors present their strategic report on the company for the year ended 31 December 2017.

Principal Activities

Path Investments Plc is a public company incorporated under the Companies Act 1985 and domiciled in the United Kingdom. The objective of the Company is to acquire oil and gas production, or near production, assets which possess a lower risk profile than exploration or appraisal assets.

Business Review

The strategy of the Company is to acquire interests in oil and gas production or near production assets with the objective of providing the Company's shareholders with access to a low risk and, over time, diversified oil and gas portfolio which can offer a dividend stream as well as offering development potential for capital growth. In March 2017, in order to pursue this strategy, the company raised gross proceeds of £1.4 million through a placing of its shares and successful Admission to the Standard List segment of the Official List of The London Stock Exchange.

The requirements of the enhanced business review are contained in the Chairman's Statement and in the Operational and Financial Reviews.

Key performance indicators

The Company has not traded over the past twelve months and no material level of interest income has been received to date.

Position of the Company's business at the year-end

At the year-end, the Company's Statement of Financial Position shows net liabilities totalling £13,698.

The future plans of the Company

The Company is in the process of raising funds on listing on the Alternative Investment Market of the London Stock Exchange. The funds are to be used for the acquisition of a 50% participating interest in the producing Alfeld-Elze II Licence and Gas Field in Lower Saxony, Germany.

Employees

The Company's only employees are its two executive directors. There are no other employees.

Employee gender diversity

Male

Female

Directors of the company

4

-

Total number of employees

2

-

Principal risks and uncertainties

The Company is subject to various risks relating to investments, industry, business and financial conditions. The following risk factors, which are not exhaustive, are particularly relevant to the Company and its business activities:

 

Risk

Mitigation

Due diligence on potential investments

Any due diligence by the Company in connection with a proposed investment may not reveal all relevant considerations or liabilities, which could have a material adverse effect on the Company's financial condition or results of operations. There can be no assurance that the due diligence undertaken with respect to a potential investment opportunity will reveal all relevant facts that may be necessary to evaluate such opportunity. The Company may also make subjective judgements regarding the results of operations, financial condition and prospects of a potential investment opportunity which by their nature may subsequently result in substantial impairment charges or other losses.

 

The Company intends to conduct such due diligence as it deems reasonably practicable and appropriate based on the facts and circumstances applicable to any potential investment prior to entering into any legally binding agreement in connection therewith to acquire any assets. The objective of the due diligence process will be to identify material issues which might affect the decision to proceed with any one particular investment opportunity or the consideration payable for that investment.

Lack of control over investment

It is likely that, in many cases, the Company will acquire an interest in an underlying asset which does not confer upon it the ability to control the underlying asset. Accordingly, the Company's decision making authority may be limited. Such investments may also involve the risk that such other stakeholders may become insolvent or unable or unwilling to fund additional investments in the underlying asset.

 

The Company will seek the greatest protection it can when negotiating the investment instrument. The company considers contingency plans in the event of default or non-performance of partners or material counterparties.

Operational risk in sector

Activities in the oil and gas sectors can be dangerous and may be subject to interruption. The assets in which the Company will make investments are subject to the significant hazards and risks inherent in the oil and gas sector and countries in which the underlying assets are located. Disruption caused by such risks could affect the Company's performance, financial condition and business prospects.

 

The Company will make use of industry norm insurance arrangements as well as ensuring best operational practices are strictly adhered to.

Lack of operational control

The Company will need to rely on third parties to operate its assets and will not have direct control over production from its assets. Any failure by an external contractor may lead to delays or curtailment of the production, transportation, refining or delivery of oil and gas and related products and result in adverse effect on the revenues to the Company.

 

The Company will, through its membership of each respective asset's Operational Committee, have direct involvement in day to day decisions.

Additional cost contribution

The Company may be required to contribute to unexpected costs in the underlying assets in which it invests.

 

Whilst it is difficult to mitigate against unexpected costs, best operational practises and tight budgetary control mitigate to assist in the avoidance of such events.

Investments that do not proceed to completion

The Company expects to incur certain third party costs associated with any investment opportunity that may ultimately lead to a completed transaction. The greater the number of these deals that do not reach completion, the greater the impact of such costs on the Company's performance, financial condition and business prospects.

 

The Company will seek to minimise such costs with reference to its current financial resources

Oil and gas market conditions

The Company's revenues, profitability and future growth are substantially dependent on prevailing prices of oil and natural gas and its ability to either enter into, realise or seek a return from its investments. Prices for oil and natural gas are subject to large fluctuations in response to a number of factors including relatively minor changes in the supply of, and demand for, oil and natural gas, in addition to other factors beyond the control of the Company.

The Company takes a conservative approach to making investment decisions and these decisions are based upon a detailed assessment of expected future oil and gas prices. The methodologies used to assess investments against future energy prices are in line with best practice generally adopted in the oil and gas industry.

 

Foreign currency exposure

Investments in overseas assets will expose the Company to exchange rate fluctuations.

 

The Company may seek to manage its foreign exchange exposure by active use of hedging and derivative instruments.

 

Further funding for investments

The Company's investments or future acquisitions, expansion, activity and/or business development will require additional capital, whether from equity or debt sources. There can be no guarantee that the necessary funds will be available on a timely basis, on favourable terms, or at all, or that such funds if raised, would be sufficient.

 

The Company will not enter into any binding agreement without assurance of requisite funding being in place. The company is actively seeking to diversify its sources of funding to mitigate against the risk of any single source becoming inaccessible.

Credit & Counterparty risks

Any investment concluded by the Company could underperform due to one or more of the partners or counterparties (both suppliers and customers) to the project defaulting or not performing.

The Company considers the credit and counterparty risks of the different partners and customers in any investment it considers and where necessary seeks to transfer, insure or prepares contingency plans in the event of default or non-performance.

 

Regulatory Risks

In all EU markets where access to markets and to most of the logistical infrastructure are regulated the Company is exposed to changes in regulations that could substantially alter the economics of market access and logistics. In turn, this could alter the economics of investments in hydrocarbons. Similarly, all markets have regulated fiscal regimes for hydrocarbons and changes to these hydrocarbon regimes could materially impact the returns on investments.

The Company will invest in countries with established and stable regulatory regimes and actively monitors the regulatory policies and regimes to anticipate and wherever possible mitigate the impact of regulatory changes.

 

The Strategic Report was approved by the board of directors and signed on its behalf by:

Christopher Theis

Chief Executive Officer

 

INDEPENDENT AUDITORS' REPORT TO THE SHAREHOLDERS OF PATH INVESTMENTS PLC FOR THE YEAR ENDED 31 DECEMBER 2017

Opinion

We have audited the financial statements of Path Investments Plc (the 'company') for the year ended 31 December 2017 which comprise the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity, the Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and International Financial Reporting Standards (IFRSs) as adopted by the European Union.

In our opinion, the financial statements:

give a true and fair view of the state of the company's affairs as at 31 December 2017 and of its loss for the period then ended;

have been properly prepared in accordance with IFRSs as adopted by the European Union; and

have been prepared in accordance with the requirements of the Companies Act 2006 and Article 4 of the IAS Regulation.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report.

We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard as applied to listed public interest entities, and we have fulfilled our other ethical responsibilities in accordance with these requirements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Material uncertainty related to going concern

We draw your attention to note 1.2 in the financial statements, which indicates that the Company has a net deficit on its balance sheet of £228,182 and would not be able to pay its creditors if so required. The Company is seeking to raise funds by a placing of ordinary shares at the time of its proposed admission to AIM, however, if the admission to AIM does not take place in a timely manner or the Company's creditors demand payment the Company would need to immediately raise additional funds. As stated in note 1.2, these events or conditions, indicate that a material uncertainty exists that may cast significant doubt on the Company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.

Key audit matters

Key audit matters are those matters that, in our professional judgment, are of most significance in our audit of the financial statements of the current period and would include the most significant assessed risks of material misstatement (whether or not due to fraud) we identified, including those which had the greatest effect on: the overall audit strategy, the allocation of resources in the audit; and directing the efforts of the engagement team. For this audit we determined that there were no key audit matters applicable to the Company to communicate in our report.

Our application of materiality

The scope of our audit was influenced by our application of materiality. We set certain quantitative thresholds for materiality. These, together with qualitative considerations, helped us to determine the scope and the nature, timing and extent of our audit procedures on the individual financial statement line items and disclosures and in evaluating the effect of misstatements, both individually and in aggregate on the financial statements as a whole.

Based on our professional judgement, we assessed materiality for the financial statements of the Company as follows:

Materiality

£1,685

How we determined it

1% of gross assets

Rationale for benchmark applied

We believe that gross assets is the primary measure used by shareholders in assessing the performance of the entity, and is a generally accepted auditing benchmark.

We agreed with the Directors that we would report to them misstatements identified during our audit above £84 as well as misstatements below that amount that, in our view, warranted reporting for qualitative reasons.

The were no misstatements identified during the course of our audit that individually, or in aggregate, were considered to be material in terms of their absolute monetary value or on qualitative grounds.

An overview of the scope of our audit

We tailored the scope of our audit to ensure that we performed enough work to be able to give an opinion on the financial statements as a whole, taking into account the structure of the Company, the accounting processes and controls, and the industry in which it operates.

Path Investments PLC is an oil and gas company which did not make any acquisitions during the year, and as such there were few transactions during the year.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information; we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion the part of the directors' remuneration report to be audited has been properly prepared in accordance with the Companies Act 2006.

In our opinion, based on the work undertaken in the course of the audit:

the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

 

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement included within the directors' report, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: http://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Other matters which we are required to address

We were appointed by the Directors of the Company on 6 April 2017 to audit the financial statements for the period ending 31 December 2017. Our total uninterrupted period of engagement is 12 years, covering the periods ending 30 June 2005 to 31 December 2017.

The non-audit services prohibited by the FRC's Ethical Standard were not provided to the Company and we remain independent of the Company in conducting our audit.

Those non-audit services provided during the year are detailed in note 4 to the financial statements.

Our audit opinion is consistent with the additional report to the audit committee.

Use of our audit report

This report is made solely to the Company's members, as a body, in accordance with chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Gary Miller (Senior Statutory Auditor)

For and on behalf of H W Fisher & Company

Chartered Accountants

Statutory Auditor

Acre House

11/15 William Road

London

NW1 3ER

United Kingdom

Date: 4 June 2018

 

STATEMENT OF COMPREHENSIVE INCOME FOR THE YEAR ENDED 31 DECEMBER 2017

 

Year ended

31 December

 

Year ended

31 December

Note

2017

2016

£

£

Administrative expenses

(585,533)

(782,195)

Total administrative expenses

(585,533)

(782,195)

Operating loss

4

(585,533)

(782,195)

Finance income

6

56

8

Finance cost

6

(38,500)

(75,500)

Amounts written off investments

11

-

(1,050,000)

Loss on ordinary activities before taxation

(623,977)

(1,907,687)

Tax on loss on ordinary activities

8

-

-

Loss for the year and total comprehensive loss for year

(623,977)

(1,907,687)

Loss per share (pence)

- Basic & diluted

9

(0.42)

(8.74)

All operating income and operating gains and losses relate to continuing activities.

The notes form an integral part of the financial statements.

 

STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31 DECEMBER 2017

 

 

Share Capital

Share Premium

Share based payments reserve

Retained earnings

Total

£

£

£

£

£

As at 1 January 2016

8,578,088

24,134,750

715,752

(32,994,924)

433,666

Comprehensive income

Loss for the period

 

-

 

-

 

-

 

(1,907,687)

 

(1,907,687)

Issue of share capital

227,750

-

-

-

227,750

As at 31 December 2016

8,805,838

24,134,750

715,752

(34,902,611)

(1,246,271)

Comprehensive income

Loss for the period

 

-

 

-

 

-

 

(623,977)

 

(623,977)

Issue of share capital

173,929

1,565,363

-

-

1,739,292

Issue costs

-

(286,496)

-

-

(286,496)

Lapsed or waived share options

-

-

(382,479)

382,479

-

Transfer to retained reserves

-

-

(333,273)

333,273

-

Share based payment

-

-

-

403,752

403,752

As at 31 December 2017

8,979,767

25,413,617

-

(34,407,084)

(13,700)

The Share Capital represents the nominal value of the equity shares.

The Share Premium represents the amount subscribed for share capital, in excess of the nominal amount, less costs directly relating to the issue of shares.

The Share Based Payments reserve represents the fair value of the equity settled share options.

The Retained Earnings reserve represents the cumulative net gains and losses less distributions made.

The notes form an integral part of the financial statements.

 

STATEMENT OF FINANCIAL POSITION AS AT 31 DECEMBER 2017

As at 31 December 2017

As at 31 December 2016

£

£

Note

ASSETS

Non-current assets

Property, plant and equipment

10

-

-

Investments - available for sale

11

-

-

-

-

Current assets

Trade and other receivables

12

8,978

90,700

Cash and cash equivalents

16

159,505

23,672

168,483

114,372

LIABILITIES

Current liabilities

Trade and other payables

13

(182,183)

(1,360,643)

Net Current Liabilities

(13,700)

(1,246,271)

NET LIABILITIES

(13,700)

(1,246,271)

 

SHAREHOLDERS' EQUITY

Called up share capital

14

195,943

22,014

Deferred shares

14

8,783,824

8,783,824

Share premium account

25,413,617

24,134,750

Share based payments reserve

-

715,752

Retained earnings

(34,407,084)

(34,902,611)

TOTAL EQUITY

(13,700)

(1,246,271)

The financial statements were approved by the board of directors and authorised for issue on 4 June 2018 and signed on its behalf by:

C Theis

Chief Executive Officer

The notes form an integral part of the financial statements.

 

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2017

Notes

Year ended 31 December

2017

Year ended 31 December

2016

£

£

Cash flows from operating activities

Cash expended from operations

15

(1,317,018)

(307,376)

Net cash outflow from operating activities

(1,317,018)

(307,376)

Cash flows from investing activities

Interest received

56

8

Net cash generated from investing activities

56

8

Cash flows from financing activities

Net proceeds from the issue of ordinary shares

1,452,795

227,750

Net cash inflow from financing activities

1,452,795

227,750

Net increase/(decrease) in cash and cash equivalents

135,833

(79,618)

Cash and cash equivalents at beginning of year

23,672

103,290

Cash and cash equivalents at end of year

16

159,505

23,672

The notes form an integral part of the financial statements.

 

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2017

 

1. ACCOUNTING POLICIES

1.1 Basis of preparation

Path Investments Plc is a public limited company incorporated in the United Kingdom, registered under company number 04006413. The address of the registered office is Aston House, Cornwall Avenue, London, N3 1LF. The principal activity of the Company is the investment in oil and gas development and production companies.

The financial statements have been prepared and approved by the Directors in accordance with International Financial Reporting Standards as adopted by the European Union ('IFRS') and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

The financial statements are presented in UK Sterling and all values are rounded to the nearest pound except where indicated otherwise.

The financial statements have been prepared under the historical cost convention or fair value where appropriate. The significant accounting policies adopted are described below.

The financial statements disclose information about the company only and not its group on the basis that its subsidiaries are dormant and have not traded (see note 21).

1.2 Going concern

The Directors have prepared the financial statements on a going concern basis. The Directors consider the use of the going concern assumption to be appropriate. At the latest reported date of 31 December 2017, the Company had cash and cash equivalents totalling £159,505 and since then has raised additional funds of £68,000 through the issue of convertible loans. As at 31 March 2018 the Company had cash equivalents totalling £11,939 and had a net deficit on its balance sheet of £228,182. The Company is therefore able to continue as a going concern only as a result of the support of its creditors. As announced, the Company is seeking to raise further funds by a placing of ordinary shares at the time of its proposed admission to AIM and conditional acquisition of a 50% participating interest in an onshore producing conventional gas field, the Alfeld-Elze II Licence and Gas Field in Germany. Should the placing and the admission to AIM not take place in a timely manner, or should the Company's creditors demand payment, the Directors will need to immediately raise additional funds in order to be able to continue as a going concern. The ability of the Company to raise additional funds is dependent upon investor appetite and if necessary the Directors' ability to obtain alternative sources of funding.

For the above detailed reasons the Directors believe there is a material uncertainty over the Company's status as a going concern. However, the Directors have a reasonable expectation that the Company will be able to raise sufficient funding to allow it to cover its working capital for a period of twelve months from the date of approval of the financial statements. It is for this reason they continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Financial instruments

The Company classifies financial instruments, or their component parts, on initial recognition as a financial asset, a financial liability or an equity instrument in accordance with the substance of the contractual arrangement.

Financial instruments are recognised on the balance sheet at fair value when the Company becomes a party to the contractual provisions of the instrument.

Compound financial instruments issued by the Company comprise convertible loan notes that can be converted to share capital at the option of the holder, and the number of shares to be issued does not vary with changes in their fair value.

The liability component of the compound financial instrument is initially recognised at fair value of a similar liability that does not have an equity conversion option. The equity component is initially recognised at the difference between the fair value of the compound financial instrument as a whole and the fair value of the liability component. Any directly attributable transaction costs are allocated to the liability and equity components in proportion to their initial carrying amounts.

Subsequent to initial recognition, the liability component of a compound financial instrument is measured at amortised cost using the effective interest rate method. The equity component of a compound financial instrument is not re-measured subsequent to initial recognition except on conversion or expiry.

1.4 Financial assets

Loans and receivables

Loans and receivables are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They are included in current assets, except for maturities greater than 12 months after the end of the reporting period. These are classified as non-current assets. Loans receivable are carried at amortised cost. The Directors assess at the end of each reporting period whether there is objective evidence that a financial asset is impaired. Any impairment shall be recognised in the Statement of Comprehensive Income.

Investments - available for sale

Investments are recognised and derecognised on a trade date where a purchase or sale of an investment is under a contract whose terms require delivery of the investment within the timeframe established by the market concerned and are initially measured at cost, including transaction costs.

Unlisted investments are recorded at cost less impairment. Unlisted investments are instruments that do not have a quoted market price in an active market and their fair value cannot be measured reliably. The range of reasonable fair value estimates is significantly wide and the probabilities of the various estimates cannot be reasonably assessed as they relate to the underlying gas reserves in blocks which are currently being explored by a third party company.

Impairment

The Company assesses at each reporting date whether there is objective evidence that assets, financial assets or a group of financial assets are impaired. Assets are considered impaired if, and only if, there is objective evidence of impairment as a result of one or more events that has occurred after the initial recognition of the asset and that the loss event has an impact on the estimated future cash flows of the asset that can be reliably measured.

1.5 Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as interest bearing loans and borrowings in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the Income Statement. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited directly to equity.

1.6 Cash and cash equivalents

Cash and cash equivalents comprise cash in hand and at bank and other short-term deposits. They are stated at carrying value which is deemed to be fair value.

1.7 Property, plant and equipment

Property, plant and equipment are stated at cost on acquisition less accumulated depreciation and accumulated impairment losses.

Depreciation is provided on all property, plant and equipment categories at rates calculated to write off the cost, less estimated residual value on a straight line basis over their expected useful economic life. The depreciation rates are as follows:

Basis of depreciation

Office equipment 3 years straight line

1.8 New Standards and Interpretations

The IASB and IFRIC have issued the following standards and interpretations which are in issue but not in force at 31 December 2017:

Effective date (period beginning on or after)

IFRS 2

Share based payments - Amendments to clarify the classification and measurement of share-based payment transactions

1 January 2018

IFRS 3, IFRS 11, IAS 12, IAS 23, IAS 28

Business combinations - amendments resulting from annual improvements 2015-2017 cycle

1 January 2019

IFRS 4

Insurance contracts - Amendments regarding the intergration of IFRS 4 and IFRS 9

1 January 2018

IFRS 9

Financial instruments - incorporating requirements for classification and measurement, impairment, general hedge accounting and de-recognition.

1 January 2018

IFRS 9

Financial instruments - amendments regarding prepayment features with negative compensation and modification of financial liabilities

1 January 2019

IFRS 15

Revenue from Contracts with Customers - Clarifications to IFRS 15

1 January 2018

IFRS 16

Leases - original issue

1 January 2019

IAS 19

Employee benefits -amendments regarding plan amendments, curtailments or settlements

1 January 2019

IAS 28

Long-term interests in associates and joint ventures

1 January 2019

IFRIC 22

Foreign currency transactions and advance consideration

1 January 2018

The Directors anticipate that the adoption of these Standards and Interpretations in future periods will have no material impact on the financial statements other than in terms of presentation.

1.9 Share-based payments

The Company operates a number of equity-settled share-based compensation plans, under which the entity receives services from employees or suppliers as consideration for equity instruments (options) of the Company. The fair value of the employee or supplier services received in exchange for the grant of options is recognised as an expense. The total amount to be expensed is determined by reference to the fair value of the options granted:

· including any market performance conditions;

· excluding the impact of any service and non-market performance vesting conditions (for example, profitability, sales growth targets and remaining an employee of the entity over a specified time period); and

· excluding the impact of any non-vesting conditions (for example, the requirement of employees to save).

Non-market vesting conditions are included in assumptions about the number of options that are expected to vest. The total expense is recognised over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. At the end of each reporting period, the entity revises its estimates of the number of options that are expected to vest based on the non-marketing vesting conditions. It recognises the impact of the revision to original estimates, if any, in the income statement, with a corresponding adjustment to equity.

When the options are exercised, the Company issues new shares. The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.

1.10 Taxation

Current tax, including UK corporation tax and foreign tax, is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantially enacted by the balance sheet date.

Deferred tax is recognised, using the liability method, in respect of temporary differences between the carrying amount of the Company's assets and liabilities and their tax base.

Deferred tax liabilities are offset against deferred tax assets. Any remaining deferred tax asset is recognised only when, on the basis of all available evidence, it can be regarded as probable that there will be suitable taxable profits, within the same jurisdiction, in the foreseeable future against which the deductible temporary difference can be utilised.

Deferred tax is determined using tax rates that are expected to apply in the periods in which the asset is realised or liability settled, based on tax rates and laws that have been enacted or substantially enacted by the balance sheet date.

Current and deferred tax are recognised in the income statement, except when the tax relates to items charged or credited directly in equity, in which case the tax is also recognised in equity.

1.11 Sources of estimation uncertainty

The preparation of financial statements requires the use of estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reporting amount of income and expenses during the period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results ultimately may differ from those estimates.

Share based payments

The share-based payment charge is calculated using the Black-Scholes model which requires the estimation of share price volatility, expected life and the bid price discount.

2. SEGMENTAL REPORTING

a. Primary segment - business

The Company has only one business segment, which is investing in oil and gas assets, either by way of equity or convertible loans primarily in the natural resources sector.

b. Secondary segment - geographical

The Company's loss for the period was derived wholly from activities undertaken in the United Kingdom.

The Company's net assets are located entirely in the United Kingdom.

3. EXPENSES BY NATURE

2017

2016

£

£

Staff costs

(620,838)

412,012

Share based payment

400,346

-

Other expenses

806,025

370,183

585,533

782,195

 

 

4. OPERATING LOSS

The operating loss is stated after charging:

 

2017

2016

£

£

Auditors remuneration - audit services

24,000

24,000

 

 

Non- Audit Services

Reporting accountants services in respect off the company's Standard Listing

 

38,845

 

-

Services in relation to proposed listing on the Alternative Investment Market

 

47,700

Total non-audit fees

86,545

 

5. EMPLOYEES

Number of employees

The average monthly number of employees (including Directors) during the period was:

 

2017

2016

 Number

 

Number

Administration

4

3

2017

2016

£

£

Employment costs

Wages and salaries (including benefits in kind)

Social security costs

Pension costs

(520,091)

(56,008)

(44,739)

(620,838)

375,262

27,750

9,000

412,012

 

 

Included in employment costs above is a waiver of accrued remuneration of £940,905 (2016: £275,850).

6. FINANCE INCOME AND COSTS

 

2017

 

2016

£

£

Finance Income

Bank interest

56

8

56

8

Finance costs

Bank charges

(1,000)

-

Convertible loan note interest

(37,500)

(75,500)

Net finance cost

(38,444)

(75,492)

 

7. DIRECTORS' REMUNEREATION

 

2017

 

2016

£

£

Aggregate emoluments

(520,091)

375,262

Share based payment

400,346

-

Pension costs

(44,739)

9,000

 

 

(164,484)

384,262

 

 

The Directors continued to work without payment of their remuneration until March 2017 when the Company was listed on the Standard Market and waived their accrued salaries and pension costs to that date totalling £940,904.

 

The highest paid Director received remuneration of £186,496 (2016: £117,263) including a gross bonus of £94,621 paid to C Theis in recognition of his efforts in assisting the company's listing on the Standard Market and associated fundraising.

During the period, retirement benefits accrued to no Directors (2016: 1).

 

8. TAXATION

No corporation tax charge arises in respect of the period due to the trading losses incurred. The Company has surplus management expenses available to carry forward and use against trading profits arising in future periods of £4,304,744 (2016: £4,319,873). In addition the Company has non-trading loan relationship debits to carry forward to offset against future non-trading loan relationship credits of £18,880,043 (2016: £18,880,318).

 

 

2017

 

 2016

£

£

Current tax charge

-

-

Loss on ordinary activities before taxation

(623,977)

(1,907,687)

 

 

 

Loss on ordinary activities before taxation multiplied by average effective rate of corporation tax of 19% (2016: 20%)

 

(118,556)

(381,537)

 

 

Effects of:

Non-deductible expenses

131,856

242,085

Capital allowances in excess of depreciation

-

-

Depreciation in excess of capital allowances

-

282

Short term timing differences

(178,771)

89,593

Other adjustments

-

-

Movement in tax losses

165,471

49,577

Current tax charge

-

-

A deferred tax asset of £873,494 (2016: £743,478) in respect of losses has not been recognised due to the uncertainty regarding the availability of future profits against which the losses of the Company could be offset.

 

9. LOSS PER SHARE

The calculation of the basic and diluted loss per share is based on the loss on ordinary activities after taxation of £623,977 (2016: £1,907,687) and on the weighted average number of ordinary shares of 149,164,700 (2016: 21,824,355) in issue. The basic and diluted loss per share is 0.42p (2016: 8.74p). As the Company is loss making, there was no dilutive effect from the share options or warrants.

In order to calculate the diluted earnings per share, the weighted average number of ordinary shares in issue is adjusted to assume conversion of all dilutive potential ordinary shares according to IAS33. Dilutive potential ordinary shares include convertible loan notes and share options granted to Directors and consultants where the exercise price (adjusted according to IAS 33) is less than the average market price of the Company's ordinary shares during the period.

 

10. PROPERTY, PLANT AND EQUIPMENT

 

Office equipment

Cost

£

At 1 January 2017

4,233

At 31 December 2017

4,233

Accumulated depreciation

At 1 January 2017

4,233

Charge for the year

-

At 31 December 2017

4,233

Net book value at 31 December 2017

-

Net book value at 31 December 2016

-

 

11. INVESTMENTS - AVAILABLE FOR SALE

Unlisted Investments

Total

£

£

At 1 January 2016

1,050,000

1,050,000

Impairment

(1,050,000)

(1,050,000)

At 31 December 2016

-

-

Additions

At 31 December 2017

-

-

Unlisted investments are recorded at cost less impairment. Unlisted investments are instruments that do not have a quoted market price in an active market and their fair value cannot be measured reliably. The range of reasonable fair value estimates is significantly wide and the probabilities of the various estimates cannot be reasonably assessed as they relate to the underlying gas reserves in blocks which are currently being explored by a third party company.

The unlisted investments as at 31 December 2016 and 31 December 2017 comprised of a 5 per cent. interest each in ARAR and Alpay Enerji as at an aggregate cost of £8 million. In 2016, Mr. S. Faith Alpay, the majority owner of ARAR and Alpay Enerji AS, made an initial offer to the Company of £1,050,000 for its 5% interest in both companies payable in instalments. However, since the offer was received, progress towards a legal sale and purchase agreement had not occurred, and as the payment was by instalment over a period of time, the directors considered the likelihood of finding an alternative buyer to be low and accordingly impaired the asset to £nil in the year ended 31 December 2016.

 

12. TRADE AND OTHER RECEIVABLES

2017

2016

£

£

Prepayments

8,978

90,700

8,978

90,700

 

 

 

13. TRADE AND OTHER PAYABLES

2017

2016

£

£

Trade payables

38,711

140,740

Taxation and social security

8,542

-

Other payables

-

151,000

Accruals and deferred income

134,930

1,068,903

182,183

1,360,643

 

 

Included in other payables at 31 December 2016 is £75,500 raised from the Directors in respect of Convertible Unsecured Loan Stock 2016 together with accrued interest thereon of £75,500.

Convertible Unsecured Loan Stock 2016

In October and December 2016, the Company raised £75,500 under the Convertible Unsecured Loan Stock 2016 instrument issued on 26 October 2016. In January and February 2017, the Company raised a further £37,500 under the instrument. From the total of £113,000, the following amounts were raised from the directors:

Director

£

D Boylan

20,000

C Theis*

67,000

R Patel**

3,000

A Yeo

10,000

N Fitzpatrick***

10,000

T Corrado

3,000

Total

113,000

* £57,000 from Chris Theis's Pension fund and £10,000 from Networkguru Limited, a company owned and controlled by Chris Theis' son

** Including £1,500 from Adler Shine LLP, a firm in which Rakesh Patel has an interest.

*** From Ocean Park Developments Limited, a company controlled by N Fitzpatrick

At the option of the loan stockholder, on an Admission of the Company to AIM or other recognised investment exchange, the loan would either be convertible into shares at the price at which the placing associated with the listing occurs or would be repayable out of the placing proceeds together with 100% interest to compensate for the risk associated with the loan. On the Standard Listing of the Company in March 2017, the loans were either repaid or converted into shares. Directors loans of £198,000 (including related interest of £106,500) were converted into shares. In total £203,000 was converted into shares, and £23,000 was repaid of which £21,500 related to loans from Directors.

 

14. SHARE CAPITAL

Allotted, called up and fully paid - Ordinary Shares

Ordinary Shares of 0.1p each

Ordinary Shares of 40p each

no

£

no

£

At 1 January 2016

21,445,221

8,578,088

Share issues

On 23 March 2016 the company issued 62,500 Ordinary shares at par

 

62,500

 

25,000

On 4 April 2016 the company issued 69,375 Ordinary shares at par

 

69,375

 

27,750

On 10 May 2016 the company issued 400,000 Ordinary shares at par

 

400,000

 

160,000

On 20 May 2016 the company issued 25,000 Ordinary shares at par

 

25,000

 

10,000

On 2 June 2016 the company issued 12,500 Ordinary shares at par

 

12,500

 

5,000

22,014,596

8,805,838

In October 2016, the Company passed an ordinary resolution to subdivide the existing 22,014,596 Ordinary shares of 40 pence each into 22,014,596 New Ordinary shares of 0.1 pence and 22,014,596 Deferred shares of 39.9 pence. The above subdivision also applies to outstanding share options and warrants in October 2016.

 

 

 

22,014,596

 

 

 

22,014

(22,014,596)

(8,805,838)

At 31 December 2016

22,014,596

22,014

-

-

On 30 March 2017 the company issued 1,400,000 Ordinary shares at par

140,000,000

140,000

 

 

On 16 May 2017 the company issued 20,300,000 Ordinary shares at par on conversion of loans

20,300,000

20,300

 

 

On 16 May 2017 the company issued 13,629,206 Ordinary shares at par in satisfaction of invoices

13,629,206

13,629

 

 

At 31 December 2017

195,943,802

 195,943

 

 

The ordinary shares shall confer upon the holders the right to receive dividends and other distributions and participate in the income or profits of the company, provided that the Ordinary shares shall not confer upon the holders the rights to receive dividends paid, made or declared of the proceeds of the sale of assets held by the Company at 10 October 2016 and included on the Company's Balance Sheet as "Investments - Available for Sale" as at the date of the General Meeting (the "Legacy Assets").

The deferred shares shall confer upon the holders the following rights and shall be subject to the following restrictions, not withstanding any other provisions in these Articles:

Return of Capital

On return of assets on a winding up of the Company after the holders of Ordinary shares have received the aggregate amount paid up thereon plus £10,000,000 for each such share held by them, there shall be a distribution to the holders of deferred shares an amount equal to the nominal value of shares held and thereafter any surplus held will be distributed to holders of ordinary shares.

Dividends

Holders of deferred shares have no rights to dividends or other distributions or to participate in the income and profits of the company, except that deferred shareholders have a right to receive any dividends declared, made or paid out of the proceeds of the sale of Legacy Assets.

Transfers

The company may acquire all or any of the deferred shares in issue at any time for no consideration.

 

15 RECONCILIATION OF OPERATING LOSS TO NET CASH OUTFLOW FROM OPERATING ACTIVITIES

 

2017

 

2016

£

£

Operating loss

(585,533)

(782,195)

(Increase)/decrease in debtors

81,722

(83,730)

Increase/(decrease) in creditors within one year

(1,178,462)

632,638

Depreciation

-

1,411

Share based payment

403,755

-

Convertible loan note interest

(38,500)

(75,500)

Net cash outflow from operating activities

(1,317,018)

(307,376)

 

16. CASH & CASH EQUIVALENTS

2017

 2016

£

£

Cash at bank and in hand

159,505

23,672

 

The fair value of cash and cash equivalents at 31 December 2017 was £159,505 (2016: £23,672).

 

17. FINANCIAL INSTRUMENTS

The Company's financial instruments comprise cash and cash equivalents and various other items, such as available for sale investments and trade receivables and payables, which arise directly from its operations. It is, and has been throughout the period under review, the Company's policy to ensure that there is no trading in financial instruments. The main purpose of these financial instruments is to finance the Company's operations.

Categories of Financial Instruments

2017

2016

£

£

Financial Assets

Cash and cash equivalents

159,505

23,672

Trade and other receivables

8,978

90,700

168,483

114,372

Financial Liabilities

Trade and other payables

182,183

1,209,643

Convertible loan notes

-

151,000

182,183

1,360,643

Net Fianancial Liabilities

(13,700)

(1,246,271)

Financial Assets and Liabilities

Financial assets and financial liabilities are recognised on the Company's balance sheet when the Company becomes party to the contractual provisions of the instrument.

Financial Risk Factors

The Company's activities expose it to liquidity risk. The Company's overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on the Company's financial performance.

Liquidity Risk

The Company has to date financed its operations from cash reserves funded from share issues. Management's objectives are now to manage liquid assets in the short term through closely monitoring costs.

The Company has no borrowing facilities that require repayment and therefore has no interest rate risk exposure.

Fair Values of Financial Assets and Liabilities

The Directors consider that the fair value of the Company's financial assets and liabilities are not considered to be materially different from their book values.

18. SHARE OPTIONS

The following share options have been granted by the Company and are outstanding:

 

Date of grant

Number of ordinary shares under option at 1 January 2016

Granted during year

Exercised during year

Lapsed during year

Number of ordinary shares under option at 31 December 2016

Weighted average exercise price

Expiry date

03/05/2011

750,000

-

-

-

750,000

£2.80

02/05/2021

03/05/2011

150,000

-

-

-

150,000

£2.80

02/05/2021

23/05/2013

1,375,000

-

-

-

1,375,000

40p

23/05/2020

Total

2,275,000

-

-

-

2,275,000

£1.35

 

Date of grant

Number of ordinary shares under option at 1 January 2017

Granted during year

Exercised during year

Lapsed/ waived during year

Number of ordinary shares under option at 31 December 2017

Weighted average exercise price

Expiry date

03/05/2011

750,000

-

-

(150,000)

600,000

£2.80

02/05/2021

03/05/2011

150,000

-

-

(150,000)

-

£2.80

02/05/2021

23/05/2013

1,375,000

-

-

(1,375,000)

-

40p

23/05/2020

30/03/2017

-

32,500,000

-

-

32,500,000

0.1p

29/03/2027

30/03/2017

-

28,375,000

-

-

28,375,000

1p

29/03/2027

30/03/2017

-

12,312,500

-

-

12,312,500

2p

29/03/2027

Total

2,275,000

73,187,500

-

(1,675,000)

73,787,500

3p

All options outstanding at the year-end are exercisable at that date.

The following warrants have been granted by the Company:

 

Date of grant

Number of ordinary shares under option at 1 January 2016

Granted during year

Exercised during year

Lapsed during

year

Number of ordinary shares under option at 31 December 2016

Weighted average exercise price

Expiry date

21/11/2013

2,187,500

-

(12,500)

(2,175,000)

-

40p

20/11/2016

10/05/2016

-

125,000

-

(125,000)

-

40p

20/11/2016

 

Total

2,187,500

125,000

(12,500)

(2,300,000)

-

-

 

Date of grant

Number of ordinary shares under option at 1 January 2017

Granted during year

Exercised during year

Lapsed during

 year

Number of ordinary shares under option at 31 December 2017

Weighted average exercise price

Exercise date

30/03/2017

-

1,400,000

-

-

1,400,000

1p

29/03/2019

 

Total

-

1,400,000

-

-

1,400,000

1p

 

The fair value of equity settled share options and warrants granted is estimated at the date of grant using a Black-Scholes option pricing model, taking into account the terms and conditions upon which the options were granted. The following table lists the inputs to the model:

Options

Options

Options

Warrants

Date of grant

Expected volatility

Expected life

Risk-free interest rate

Expected dividend yield

Possibility of ceasing employment before vesting

Fair value per option

03 May 2011

 54%

3.5 years

1.72%

-

-

-

 0.014p

23 May 2013

54%

3.5 years

0.55%

-

-

-

0.004p

30 Mar 2017

33.9%

3 years

0.18%

-

-

-

0.9p/0.243p/0.1p

30 Mar 2017

33.9%

3 years

0.18%

-

-

-

0.243p

 

The expense recognised by the Company for share based payments during the year ended 31 December 2017 was £403,755 (2016: £Nil).

The average volatility is used in determining the share based payment expense to be recognised in the period. This was calculated by reference to the standard deviation of the share price over the preceding 12-month period.

Movement in the number of options and warrants outstanding and their related weighted average exercise price are as follows:

 

At 31 December 2017 At 31 December 2016

 

Number of Options & Warrants

 

 

Weighted average exercise price per share (pence)

 

Number of Options & Warrants

 

 

Weighted average exercise price per share (pence)

 

 

 

 

 

At 1 January

 

2,275,000

 

135p

 

4,462,500

 

88p

Granted

74,587,500

1p

125,000

40p

Exercised

-

-

(12,500)

40p

Expired or waived

 

(1,675,000)

83p

(2,300,000)

40p

At 31 December

75,187,500

3p

2,275,000

135p

The weighted average remaining contractual life of options as at 31 December 2017 was 9.2 years (2016: 3.8 years).

 

19. RELATED PARTY TRANSACTIONS

During the year Adler Shine LLP, a firm in which R Patel is a partner and who was a director until May, invoiced the Company £47,984 (2016: £96) for assisting in the Standard Listing of the Company, provision of bookkeeping and accountancy services, and provision of payroll and auto-enrolment pension services. The above transactions were on a commercial arm's length basis.

R. Patel charged the Company £7,500 for work done in assisting in the Standard Listing of the Company

During the year, the director C. Theis charged the Company £7,500 for assisting in the Standard Listing of the Company.

During the year the following shares were issued at par to directors:

Director

Shares issued

C Theis

11,400,000

A Yeo

4,500,000

N Fitzpatrick

2,000,000

T Corrado

600,000

 

The following share options were held by the directors during the year:

 

Director

Date of grant

Held at 1 January 2017

Lapsed during the year

Granted during the Year

Held at 31 December 2017

Exercise price

D Boylan

23/05/2013

250,000

(250,000)

-

-

£0.40

D Boylan

03/05/2011

150,000

(150,000)

-

-

£2.80

C Theis

23/05/2013

875,000

(875,000)

-

-

£0.40

D Boylan

30/03/2017

-

-

3,000,000

3,000,000

£0.001

D Boylan

30/03/2017

-

-

5,125,000

5,125,000

£0.01

D Boylan

30/03/2017

-

-

2,562,000

2,562,000

£0.02

C Theis

30/03/2017

-

-

20,000,000

20,000,000

£0.001

C Theis

30/03/2017

-

-

16,000,000

16,000,000

£0.01

C Theis

30/03/2017

-

-

6,500,000

6,500,000

£0.02

A Yeo

30/03/2017

-

-

8,500,000

8,500,000

£0.001

A Yeo

30/03/2017

-

-

6,500,000

6,500,000

£0.01

A Yeo

30/03/2017

-

-

2,875,000

2,875,000

£0.02

1,047,500

(1,047,500)

71,062,000

71,062,000

 

20. ULTIMATE CONTROLLING PARTY

The Company considers that there is no ultimate controlling party.

 

21. INVESTMENT IN SUBSIDIARIES

As at 31 December 2017 the company held more that 20% of the share capital in the following companies:

 

Subsidiary Undertaking

Country of Incorporation

Class

Shares held

Principal Activity

Path (Germany) Limited

UK

Ordinary

100%

Dormant

 

22. CONTINGENT FINANCIAL COMMITMENTS

On 14 December 2017 the Company entered into a conditional farm-in agreement with 5P Energy GmbH for the acquisition of a 50% participating interest in the producing Alfred-Elze II Licence and gas field. Under the terms of this farm-in agreement the Company has the following conditional commitments:

- €5m payable on completion of the agreement which is conditional upon the Company's admission to trading on AIM - €2m payable on the declaration of commercial production from the Z4 well.

The Company has also committed to cover certain costs associated with the project up to a maximum of €10m for the drilling, logging, testing and completion of one or more new wells and if agreed, the acquisition of 3D seismic over the field, plus 50% of Z4 costs incurred on or after 1 January 2018. Additional cash payments may become payable if certain milestones are successfully met following completion.

 

 

23. SUBSEQUENT EVENTS

On 3 April 2018 the Company constituted an instrument to issue £150,000 nominal convertible unsecured loan stock 2018. On admission of the Company to AIM or other recognised investment exchange, the convertible loan notes are, at the option of the loan note holder, either convertible into shares at the price at which the placing associated with the listing occurs or will be repayable out of the placing proceeds together with 100% interest to compensate for the risk associated with the loan. If the listing does not occur before 31 July 2018 the loan note holder may convert the loan together with interest into fully paid Ordinary Shares in the Company at the nominal value of an Ordinary Share.

Subsequently the Company raised £68,000 under this instrument. The following amounts were raised from the Directors:

Director

Amount £

C Theis

25,000

A Yeo

25,000

Total

50,000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR FIMJTMBMMBIP
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.